The brain struggles with focus and impulse control throughout various situations
Your body is working overtime to produce milk, heal from childbirth, and manage the effects of interrupted sleep
Patients with either risk factor should surface it to the clinician during async review before the first dose
Heres a The Tamagotchi, a portmanteau of tamago egg in Japaneseand the English word watch, is a virtual pet the size of a keychain
During GLP-1associated weight loss, lean-mass changes are typically adaptive and preventable , not degenerative. GLP-1 Body Composition Changes: What Clinical Trials Show About Muscle Loss Clinical trials and body-composition sub-studies of semaglutide and tirzepatide consistently demonstrate: Fat mass accounts for most weight lost during treatment. Lean mass may decrease , particularly without resistance training or adequate protein intake. In many patients, the proportion of lean mass relative to total body weight is preserved or improved , because fat loss exceeds lean loss. Key clinical insight: GLP-1/GIP therapies improve overall body composition by preferentially reducing fat massnot by causing muscle breakdown. Lean mass refers to all the non-fat tissues in the bodyprimarily skeletal muscle , but also organs, bones, connective tissue, and body waterthat support metabolism, movement, and overall physical function
